Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Investigator Initiated Study of Effects of Progression of Recurrent Respiratory Papillomatosis in Patients After They Are Given Human Papillomavirus Quadrivalent Vaccine

NCT00829608 is registered in ClinicalTrials.gov with University of Missouri-Columbia as lead sponsor.

NCT NCT00829608
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00829608 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Investigator Initiated Study of Effects of Progression of Recurrent Respiratory Papillomatosis in Patients After They Are Given Human Papillomavirus Quadrivalent Vaccine
Lead sponsor
University of Missouri-Columbia
Phase
Phase 1
Overall status
Withdrawn
Start date
January 31, 2009
Completion date
June 30, 2010
Enrollment
0 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

recurrent respiratory papillomatosis